• LINC02870 Drives SNAIL Translation and HCC Progression via E

  2026-04-24

  This study identifies the long non-coding RNA LINC02870 as an oncogenic driver in hepatocellular carcinoma (HCC) by enhancing SNAIL translation through interaction with EIF4G1. The findings illuminate a novel regulatory axis in HBV-related HCC metastasis and suggest new avenues for biomarker and therapeutic target development.

• Optimizing Genome Editing: EZ Cap™ Cas9 mRNA (m1Ψ) in Cell A

  2026-04-23

  This article provides an evidence-based, scenario-driven exploration of how EZ Cap™ Cas9 mRNA (m1Ψ) (SKU R1014) addresses common laboratory challenges in CRISPR-Cas9 genome editing. Researchers will gain practical insights on assay reproducibility, immune response suppression, and product selection, grounded in quantitative data and literature. Discover how SKU R1014 supports reliable, high-efficiency gene editing in mammalian systems.

• Methyl-β-cyclodextrin: Technical Use and Protocol Parameters

  2026-04-23

  Methyl-β-cyclodextrin (SKU C6939) is designed for selective extraction of cholesterol and certain lipids from cellular membranes, supporting membrane fluidity and lipid raft disruption studies. It is not suitable for diagnostic or medical applications and should be handled with strict attention to storage and preparation protocols for optimal experimental reliability.

• Trichostatin A (TSA): Protocols and Innovations in Cancer Ep

  2026-04-22

  Trichostatin A (TSA) stands out as a benchmark HDAC inhibitor, enabling researchers to dissect epigenetic regulation in cancer and immune models with precision. This article translates breakthrough workflows and troubleshooting tips into actionable guidance, highlighting TSA’s unique advantages as supplied by APExBIO.

• Diphenyleneiodonium Chloride: Strategic Insights for Transla

  2026-04-22

  This thought-leadership article provides translational researchers with a mechanistic and strategic synthesis of Diphenyleneiodonium chloride (DPI) as a dual-function probe in redox enzyme inhibition and cAMP signaling modulation. Drawing on recent literature, including the interplay between redox-sensitive transcription factors and viral pathogenesis, we dissect best practices, emerging challenges, and future horizons for DPI-guided workflows, while positioning APExBIO’s DPI as a tool of choice for innovative research.

• Superoxide Dismutase (SOD) Activity Assay Kit: Technical Gui

  2026-04-21

  The Superoxide Dismutase (SOD) Activity Assay Kit (K2035) provides a colorimetric, quantitative method for measuring SOD enzyme activity in biological fluids, supporting studies of oxidative stress and related pathways. It is best suited for research applications requiring reproducible, high-throughput assessment of antioxidative defense in cell, tissue, or plasma samples. This kit is not intended for diagnostic or clinical use.

• ABT-737: Precision BCL-2 Protein Inhibitor for Cancer Resear

  2026-04-21

  ABT-737 empowers researchers to induce apoptosis selectively in cancer cells by targeting BCL-2 family proteins. This guide translates cutting-edge in vitro methodologies and real-world troubleshooting strategies into actionable protocols for maximizing antitumor insights.

• Strategic PTEN mRNA Restoration: Mechanisms & Translational

  2026-04-20

  This article unpacks the mechanistic and translational landscape of PTEN mRNA-based interventions, with a focus on the EZ Cap™ Human PTEN mRNA (ψUTP) reagent. Anchored in contemporary evidence—including nanoparticle-mediated delivery to reverse drug resistance—this thought-leadership piece guides researchers from molecular rationale through protocol execution, competitive differentiation, and translational strategy. It uniquely bridges mechanistic insight, protocol optimization, and future outlook for robust, reproducible cancer research.

• Predicting Major Bleeding Risk During Extended Anticoagulati

  2026-04-20

  This study introduces and validates the CHAP model, a new tool for predicting major bleeding in patients receiving extended anticoagulation after unprovoked or weakly provoked venous thromboembolism (VTE). The model simplifies risk estimation by using continuous predictors and compares favorably with existing scoring systems, providing clinicians with clearer guidance on balancing recurrence and bleeding risks.

• ECL Western Blotting Substrate: Technical Workflow Guide

  2026-04-19

  ECL Western Blotting Substrate (SKU K2187) provides a sensitive, nonradioactive solution for detecting horseradish peroxidase (HRP) in Western blot assays, delivering strong chemiluminescent signals for protein analysis in molecular and cancer biology. This substrate is not suitable for workflows requiring fluorescent or radioisotopic detection, and its performance is optimal only when used as directed in chemiluminescent Western blotting.

• SAR405 and the Vps34-AMPK Axis: Redefining Autophagy Inhibit

  2026-04-18

  Discover how SAR405, a potent Vps34 inhibitor, enables precise dissection of autophagy signaling in light of paradigm-shifting AMPK-ULK1 research. Uncover advanced assay protocols, lysosome functional insights, and new scientific frontiers for cancer and metabolic disease studies.

• Baicalin Restores Visual Plasticity in Adult Amblyopia Model

  2026-04-17

  This study demonstrates that Baicalin, a flavone glycoside from Scutellaria baicalensis, reactivates ocular dominance plasticity and restores visual acuity in adult mice with amblyopia. These findings highlight Baicalin’s capacity to modulate cortical inhibition and open a new avenue for adult neuroplasticity interventions.

• Glabridin-Gold(I) Complex Enhances Antitumor Immunity via Tr

  2026-04-16

  Wang et al. introduce a novel glabridin-gold(I) complex (6d) that enhances antitumor immunity in liver cancer by dual inhibition of thioredoxin reductase (TrxR) and MAPK pathways. The study demonstrates 6d’s impact on the tumor microenvironment, providing mechanistic insight and preclinical evidence supporting its use in combination immunotherapy.

• BMS 599626 Dihydrochloride: Empowering Mechanistic Oncology

  2026-04-15

  This thought-leadership article explores how BMS 599626 dihydrochloride, a potent EGFR and ErbB2 inhibitor, bridges foundational cancer biology with translational workflows. By integrating mechanistic rationale, experimental validation, and strategic guidance, it equips researchers to advance reproducible oncology and senescence studies. Comparative context, rigorous protocol suggestions, and a forward-looking outlook distinguish this discussion from standard product overviews.

• Scenario-Based PI3K Inhibition: Practical Guidance Using GDC

  2026-04-14

  This article delivers scenario-driven solutions for researchers tackling PI3K/Akt pathway inhibition and cancer cell proliferation studies. Leveraging GDC-0941 (SKU A8210), we address real-world assay challenges—such as reproducibility, dosing, and vendor reliability—integrating literature-backed parameters and actionable recommendations to optimize laboratory workflows.

459 records 21/31 page Previous Next First page 上5页 2122232425 下5页 Last page